US 10696718
Compstatin analogs for treatment of neuropathic pain
granted A61KA61K38/10A61K38/12
Quick answer
US patent 10696718 (Compstatin analogs for treatment of neuropathic pain) held by Apellis Pharmaceuticals, Inc. expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Apellis Pharmaceuticals, Inc.
- Grant date
- Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K38/10, A61K38/12, A61K38/16, A61K45/06